The questionnaire covers demographics, co-morbidities, vaccination status, stay-in camp status and contact details of ill member in bunk (for stay-in personnel) and at home (for both stay-in and stay-out personnel).
Current candidates include (1) immune stimulation (for example, via co-infection or vaccination), and (2) a novel infectious agent.
In high-TB burden settings, the results of IGRAs may be influenced by factors that affect the immune response [15] such as HIV co-infection, BCG vaccination, malnutrition, tropical infections and widespread exposure to NTM.
The conserved sequences that matched with low representation may pose potential risk of altered ligands resulting in pathologic immune responses following co-infection or vaccination and secondary infection with a similar virus.
In Argentina and Brazil, BoHV-1 and BoHV-5 co-circulate and vaccination against BoHV-1 is not obligatory.
Self administered questionnaire were distributed to gather information on possible risk factors (sociodemographic, work history, BCG vaccination, co-morbid conditions, substance abuse, history of previous TB, and history of living in the same house with a family member or friend with active TB).
The effect of abatacept, a selective T-cell co-stimulation modulator, on vaccination has not been previously investigated.
The data support co-administration for combined vaccination against invasive meningococcal disease and seasonal influenza in healthy adult travelers.
The aims of this study were to investigate the frequency of FCV in cats suspected FCV infected by veterinary practitioners and in clinically healthy cats in Switzerland, and to address potential risk and protective factors for infection in both groups of cats, such as signalment, housing conditions, vaccination, and co-infection with URTD-associated pathogens.
The aims of this study were 1) to investigate the frequency of FCV in cats with FCV-related symptoms and in healthy cats in Switzerland, 2) to assess risk and protective factors for infection, such as signalment, housing conditions, vaccination, and co-infection with URTD-associated pathogens, and 3) to address the association between clinical symptoms and FCV infection.
These estimates are based on the assumption (in the best case for vaccination) that co-infection of other oncogenic types, in the presence of HPV 16 and/or 18, was not causally responsible for the development of the majority of high grade lesions in the current study; if this assumption does not hold then the proportion of vaccine-preventable high grade lesions could be considerably lower.
